The global Hematology Analyzers and Reagents Market is forecast to reach USD 12.10 Billion by 2027, according to a new report by Reports and Data. The growing demand from emerging markets will help the Hematology Analyzers and Reagents Market to maintain a stable growth rate over the forecast period. The rise in the family disposable incomes and growing adoption of automated hematology devices by the clinical labs will provide strength to the Hematology Analyzers and Reagents Market and will also help in its growth over the forecasted period.
Due to the pandemic, there are high chances of disruption in the supply chain which influence ingredients and raw material supplies. The financial crisis can let people shrink their expenses on treatments, which may lead to life risk.
Hematology Analyzers and Reagents Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Further key findings from the report suggest:
- The increasing number of blood donations arranged by different organizations worldwide are boosting the Hematology Analyzers and Reagents Market. Additionally, the growing investment in the research and development of the hematology instrument made by the leading manufacturers are also acting as a driver for the Hematology Analyzers and Reagents Market.
- The hematology products registered the largest market share of about 40.4% in the Hematology Analyzers and Reagents Market in 2019. The increasing production of technologically advanced devices and the growing adoption of Point of Care (POC) testing has generated revenue for the market.
- The Asia Pacific has the highest adoption rate in the market. This is due to the increasing demand for Hematology Analyzers and Reagents in countries like China and India and recent developments in the healthcare infrastructure.
- Hematology Analyzers and Reagents Market are adopting some wiser strategies to stay competitive in between the growing demand of the Hematology Analyzers and Reagents. Collaborations have been observed between prominent brands to increase their product portfolio and enter new markets. Companies adopt effective marketing and branding strategies to hold the position of the products in the competitive market.
Top Companies Profiled in the Report Include:
Abbott Laboratories, Roche Diagnostics, Siemens AG, Beckman Coulter, HORIBA Ltd, Nihon Kohden Corporation, Bio-Rad Laboratories, Sysmex Corporation, Boule Diagnostics AB and Mindray Medical International Limited, among others.
Additionally, the report consists a detailed analysis of the segmentation of the PTA Balloon Cathetery tests Market based on product types and end-use/application offered in the PTA Balloon Cathetery tests Market –
Product Outlook (Revenue, USD Billion; 2017-2027)
- Hematology Analyzers
- Hemostasis Analyzers
- Plasma Protein Analyzers
- Hemoglobin Analyzers
- Immunohematology Analyzers
- Others
Price range Outlook (Revenue, USD Billion; 2017-2027)
- High-end Hematology Analyzers
- Mid-range Hematology Analyzers
- Low-end Hematology Analyzers
End Users Outlook (Revenue, USD Billion; 2017-2027)
- Research Academic Institutes
- Blood Banks
- Hospital laboratories
- Commercial service Providers
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Infection Related Conditions
- Blood Cancers
- Anemia
- Hemorrhagic
- Others
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request for Customization this report - https://www.reportsanddata.com/request-customization-form/3483
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
